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Adaptive immune responses by dendritic cells
(DCs) are critically controlled by Toll-like recep-
tor (TLR) function. Little is known about modu-
lation of TLR-specific signaling by other path-
ogen receptors. Here, we have identified a
molecular signaling pathway induced by the
C-type lectin DC-SIGN that modulates TLR sig-
naling at the level of the transcription factor
NF-kB. We demonstrated that pathogens trig-
ger DC-SIGN on human DCs to activate the
serine and threonine kinase Raf-1, which sub-
sequently leads to acetylation of the NF-kB
subunit p65, but only after TLR-induced activa-
tion of NF-kB. Acetylation of p65 both pro-
longed and increased IL10 transcription to en-
hance anti-inflammatory cytokine responses.
We demonstrated that different pathogens
such as Mycobacterium tuberculosis, M. lep-
rae, Candida albicans, measles virus, and
human immunodeficiency virus-1 interacted
with DC-SIGN to activate the Raf-1-acetylation-
dependent signaling pathway to modulate
signaling by different TLRs. Thus, this pathway
is involved in regulation of adaptive immunity by
DCs to bacterial, fungal, and viral pathogens.
INTRODUCTION
Dendritic cells (DCs) are very efficient antigen-presenting
cells that play a central role in orchestrating adaptive im-
mune responses to pathogens (Banchereau and Stein-
man, 1998). DCs recognize pathogens through pattern
recognition receptors (PRRs) that are triggered by highly
conserved structures expressed by micro-organisms,
leading to DC maturation. PRR-induced DC maturation
enhances their ability to activate T cells and also leads
to the production of immunomodulatory cytokines, which
are essential for T cell priming and differentiation (Pasare
and Medzhitov, 2004; Sporri and Reis e Sousa, 2005). Im-portant PRRs are the Toll-like receptors (TLRs) that signal
via conserved pathways to induce the activation of several
transcription factors, of which nuclear factor-kB (NF-kB)
appears pivotal for DC maturation as well as cytokine
production (Ouaaz et al., 2002).
Recently, it has become evident that other PRRs also
play key roles in DC-induced immune responses. A strik-
ing example is DC-SIGN, a C-type lectin expressed by
DCs that interacts with a large array of pathogens (Geijten-
beek et al., 2000; van Kooyk and Geijtenbeek, 2003). Sev-
eral pathogens target DC-SIGN tomodulate DC-mediated
immune responses to promote their survival (van Kooyk
and Geijtenbeek, 2003). Strikingly, mycobacteria interact
with DC-SIGN to affect TLR4-mediated immune re-
sponses by DCs, suggesting that this C-type lectin modu-
lates TLR4 signaling (Geijtenbeek et al., 2003). The ligand
responsible for this DC-SIGN-mediated immune modula-
tion is ManLAM, a cell-wall component abundantly ex-
pressed by Mycobacterium tuberculosis. Binding of
ManLAM to DC-SIGN impairs lipopolysaccharide (LPS)-
induced maturation of DCs and increases the production
of the immunosuppressive cytokine interleukin-10 (IL-10)
(Geijtenbeek et al., 2003). In addition, DC-SIGN also mod-
ulates immune responses to several other pathogens, and
the immunological outcome is specific for the pathogen
(Bergman et al., 2004; Smits et al., 2005; Steeghs et al.,
2006). These findings support an important role for
DC-SIGN as an immunomodulatory receptor.
The molecular mechanisms underlying DC-SIGN-medi-
ated modulation of immune responses are poorly defined.
DC-SIGN might induce intracellular signaling that con-
verges with the TLR4-signaling pathway. Few clues have
emerged in the search for DC-SIGN-initiated signal trans-
duction routes. A role for the tyrosine kinase Syk has been
suggested based on its role in signaling induced by other
C-type lectins: Dectin-1 and C-type lectin-like receptor-2
(CLEC-2) (Brown, 2006; Rogers et al., 2005; Suzuki-Inoue
et al., 2006). The YXXL motif in the cytoplasmic tails of
Dectin-1 and CLEC-2 has been shown to recruit Syk;
a similar cytoplasmic motif is present in DC-SIGN. Also,
triggering of DC-SIGN with a stimulatory antibody has
been reported to induce phosphorylation of extracellular
signal-regulated kinase (ERK) and protein kinase B (PKB)
(Caparros et al., 2006); however, it remains unclearImmunity 26, 605–616, May 2007 ª2007 Elsevier Inc. 605
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DC-SIGN Induces p65 Acetylation via Raf-1Figure 1. DC-SIGN Signaling Modulates TLR3-, TLR4-, and TLR5-Dependent IL-10 Induction
(A) ManLAM induces IL-10 after TLR3, TLR4, and TLR5 triggering. Human iDCs were treated with TLR4 ligand LPS, TLR3 ligand poly(I:C), TLR5 ligand
flagellin, ManLAM, or combinations, and IL-10 protein amounts were measured by ELISA after 24 hr. A representative experiment of two donors is
shown. Results are presented as the means ± SD from duplicate samples.
(B) IL-10 mRNA production is also increased after TLR activation. Cells were treated similar as in (A). Specificity for DC-SIGN was determined by
preincubating the cells for 2 hr with the blocking anti-DC-SIGN antibody AZN-D2. After 6 hr of stimulation, relative IL-10 mRNA expression was
determined by quantitative real-time PCR analysis. IL-10 mRNA expression in LPS-stimulated cells was set at 1. Results are presented as the
means ± SD from at least three independent experiments.
(C) ManLAM does not affect IL-10 mRNA stability after LPS stimulation. Cells were stimulated as indicated for 3 hr, before the addition of 10 mg/ml
actinomycin D (ActD) to block transcription. At 20 min time periods, mRNA expression was quantified by real-time PCR analysis.whether these kinases play a role in the immunomodula-
tion induced by pathogenic ligands such as ManLAM.
Here, we have identified the mechanism by which
DC-SIGNmodulates TLR-dependent responses in human
DCs. Triggering of DC-SIGN by ManLAM activated the
serine and threonine kinase Raf-1, independently of TLR
signaling. Activation of Raf-1 led to acetylation of p65,
one of the key activating subunits of NF-kB, but only after
TLR signaling had activated NF-kB. Strikingly, acetylation
of p65 prolonged transcriptional activity of NF-kB and en-
hanced the transcription rate from the IL10 gene. We fur-
ther demonstrated that this Raf-1-acetylation-dependent
pathway is central to modulation of TLR-specific immune
responses elicited by DCs in response to mycobacteria,
fungi, and viruses. The identification of this signaling
pathway triggered by DC-SIGN will help further our
understanding of how pathogens elicit specific immune
responses.
RESULTS
DC-SIGN Signaling Modulates TLR3, TLR4,
and TLR5 Signaling
Mycobacteria interact with DC-SIGN to affect TLR4-
mediated immune responses by DCs, suggesting that
this C-type lectin modulates TLR4 signaling (Geijtenbeek
et al., 2003). We investigated whether binding of the cell-
wall componentManLAM fromMycobacterium tuberculo-
sis to DC-SIGN also modulated the cytokine production
induced through other Toll-like receptors besides TLR4
by stimulating primary human immature DCs (iDCs) with606 Immunity 26, 605–616, May 2007 ª2007 Elsevier Inc.either TLR3 ligand poly(I:C), TLR4 ligand LPS, or TLR5
ligand flagellin, alone and in combination with ManLAM.
After 24 hr stimulation, ManLAM increased the expression
of IL-10 protein by all three TLR ligands (Figure 1A). Simi-
larly, after 6 hr stimulation, ManLAM upregulated IL-10
mRNA by all three TLR ligands (Figure 1B). The upregula-
tion of IL-10 observed at the mRNA level correlated with
IL-10 protein expression. Indeed, the stability of existing
IL-10 transcripts after LPS stimulation was not affected
by ManLAM (Figure 1C), further indicating that the induc-
tion of IL-10 is regulated at the transcriptional level. The
modulation of TLR signaling by ManLAM was mediated
by DC-SIGN, because addition of a blocking antibody
against DC-SIGN abrogated the ManLAM-induced upre-
gulation of IL-10 production for each TLR (Figure 1B).
Thus, ManLAM binding to DC-SIGN modulates different
TLR-mediated cytokine responses.
Raf-1 Is Essential for DC-SIGN-MediatedModulation
of TLR Signaling
We investigated the molecular mechanism(s) underlying
the DC-SIGN-TLR crosstalk by employing a series of spe-
cific inhibitors directed against a broad range of poten-
tially important signaling proteins. The NF-kB inhibitor
BAY11-7082 completely abrogated the production of
IL-10 by LPS-stimulated iDCs (Figure 2A), indicative of
the important role of NF-kB in initiating transcription
from the IL10 promoter. The p38 inhibitor SB203580 par-
tially blocked the LPS-induced IL-10 mRNA expression,
although the ManLAM-induced enhancement of IL-10
mRNA expression was unaffected (Figure 2A). Noticeably,
Immunity
DC-SIGN Induces p65 Acetylation via Raf-1Figure 2. DC-SIGN-Mediated Modula-
tion of TLR-Dependent IL-10 Induction
Requires Raf Kinase Activity
(A) Relative IL-10 mRNA expression by human
iDCs treated with LPS and/or ManLAM for 6 hr
in the presence of either Raf inhibitor GW5074,
NF-kB inhibitor BAY11-7082, Syk inhibitor pi-
ceatannol, p38 inhibitor SB203580,MEK1/2 in-
hibitor U0126, PI 3-kinase inhibitor LY294002,
PKB inhibitor API-2, PKA/MSK1 inhibitor H89,
or 0.1% DMSO as a control; cells were prein-
cubated for 2 hr with inhibitors before stimuli
were added. After 6 hr of stimulation, relative
IL-10 mRNA expression was determined
by quantitative real-time PCR analysis. IL-10
mRNA expression in LPS-stimulated cells
was set at 1. Results are presented as the
means ± SD from at least three independent
experiments.
(B) Inhibition of Raf-1 blocks IL-10 upregulation
induced by ManLAM after stimulation of DCs
with different TLR ligands. Cells were stimu-
lated with ligands and Raf inhibitor GW5074
as in (A). Results are presented as the
means ± SD from at least three independent
experiments.the ManLAM-mediated upregulation of LPS-induced
IL-10 mRNA expression was completely inhibited by the
Raf kinase inhibitor GW5074, whereas it had no effect
on LPS-induced IL-10 mRNA expression (Figure 2A).
None of the other inhibitors used had any effect on the
ManLAM-mediated augmentation of the LPS-induced
IL-10 production, including the Syk kinase inhibitor picea-
tannol (Figure 2A). The Raf inhibitor blocked ManLAM-
mediated upregulation of IL-10 mRNA expression not
only after LPS stimulation, but also after stimulation with
TLR3 ligand poly(I:C) and TLR5 ligand flagellin (Figure 2B).
These data indicate that Raf kinases are essential in DC-
SIGN-induced signaling pathways leading to modulation
of TLR signaling. We therefore determined whether Raf ki-
nases are activated by binding of ManLAM to DC-SIGN.
GW5074 blocks the activities of both Raf-1 and B-Raf
(Horiuchi et al., 2006; Lackey et al., 2000). Stimulation of
iDCs with LPS for 10 min did not result in Raf-1 kinase
activity (Figure 3B), but it did result in substantial B-Raf
activity (Figure 3A). Strikingly, stimulation of iDCs with
ManLAM alone induced activation of Raf-1 but not B-Raf
kinase activity (Figures 3A and 3B). ManLAM-induced
activation of Raf-1 was completely abolished in the pres-
ence of the DC-SIGN blocking antibody AZN-D2 (Fig-
ure 3B). By using RNA interference, we silenced Raf-1
expression in primary iDCs (Figure 3D). Knockdown of
Raf-1 abrogated ManLAM-induced upregulation of IL-10
(Figure 3E). Thus, ManLAM binding to DC-SIGN leads to
activation of Raf-1 independent of TLR signaling.
DC-SIGN Activates Raf-1 through Ras
Raf-1 activation requires recruitment of Raf-1 to the mem-
brane through an interaction with the active form of the
small GTPase Ras (Baccarini, 2005). We observed thatactive Ras in iDCs is induced by ManLAM (Figure 4A).
Ras activation alone is, however, insufficient to activate
Raf-1, and additional phosphorylation on tyrosine and ser-
ine residues is required for activation. In particular, phos-
phorylation of serine 338 (Ser338) and tyrosines 340 and
341 (Tyr340 and Tyr341) is essential for activation of the ki-
nase activity of Raf-1 (Wellbrock et al., 2004). Indeed,
ManLAM induced the phosphorylation of Ser338 and
Tyr340 and Tyr341 on Raf-1 (Figure 4B). This is mediated
by DC-SIGN, because antibodies against DC-SIGN com-
pletely blocked phosphorylation on both Ser338 and
Tyr340 and Tyr341 (data not shown). Moreover, cell-
permeable Tat-peptides fused to the dominant-negative
form of Ras, Tat-RasN17, completely blocked phosphor-
ylation of Raf-1 (Figure 4B) as well as ManLAM-induced
upregulation of IL-10 (Figure 4C), demonstrating that
Raf-1 activation by ManLAM is dependent on Ras and
essential to IL-10 upregulation.
Phosphorylation of Tyr340 and Tyr341 and Ser338 has
been reported to be carried out by Src family tyrosine
kinases and p21-activated kinases (Paks), respectively
(King et al., 2001; Wellbrock et al., 2004). We pretreated
iDCs with PP2, an inhibitor of Src kinases, and toxin B,
an inhibitor of the Rho family GTPases, upstream effectors
of Paks.ManLAM-induced phosphorylation of Ser338 and
of Tyr340 and Tyr341 was inhibited by PP2 and toxin B,
respectively (Figure 4B). Moreover, we detected phos-
phorylation of both Pak and Src kinases after ManLAM
binding (data not shown). These data were confirmed
by the block in ManLAM-induced IL-10 production by
the combination of PP2 and toxin B (Figure 4C). Thus,
DC-SIGN binding by ManLAM activates Ras and the Src
and Pak kinases, which results in phosphorylation and
activation of Raf-1.Immunity 26, 605–616, May 2007 ª2007 Elsevier Inc. 607
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DC-SIGN Induces p65 Acetylation via Raf-1Figure 3. DC-SIGN Signaling Induces Raf-1 Activation, Independent of TLR4 Signaling
(A–C) Kinase activity assay of B-Raf (A)-, Raf-1 (B)-, or ERK1/2 (C)-specific immunocomplexes from cell lysates of human iDCs treated with LPS or
DC-SIGN ligand ManLAM for 10 min; cells were preincubated for 2 hr with the blocking DC-SIGN antibody AZN-D2 as indicated. Kinase activities in
either LPS (A, C)- or ManLAM (B)-stimulated cells were set at 1. Results are presented as the means ± SD from three independent experiments.
(D) Raf-1 was specifically silenced byRNA interference. DCswere transfectedwith 100 nMRaf-1 SMARTpool or control nontargeting siRNAs. At 72 hr
after transfection, B-Raf and Raf-1 mRNA was measured by quantitative real-time PCR. Results are presented as the means ± SD from two indepen-
dent experiments.
(E)Raf-1 isessential toManLAM-induced IL-10upregulation.Raf-1or control siRNAknockdownDCswere incubatedwithLPSaloneor incombinationwith
ManLAM, and IL-10 mRNA was determined as described in Figure 1A. Results are presented as the means ± SD from two independent experiments.The YXXL Motif of DC-SIGN Is Not Essential
to Raf-1 Activation
DC-SIGNcontainsanYXXLmotif in thecytoplasmicdomain
that might be involved in signaling. The YXXL motif is also
present in Dectin-1 and CLEC-2 and has been shown to re-
cruit Syk,which is essential in signalingof bothDectin-1 and
CLEC-2 (Brown, 2006; Rogers et al., 2005; Suzuki-Inoue
et al., 2006). To investigate the role of this motif, we trans-
duced Jurkat cells with DC-SIGN in which Tyr31 was re-
placed by an alanine (DC-SIGN Y31A). ManLAM induced
phosphorylation of Raf-1 in Jurkat cells expressing DC-
SIGN WT, but not in mock transduced Jurkat cells (Fig-
ure 4D), demonstrating that DC-SIGN WT induces Raf-1
activation in Jurkat cells similar to iDCs. The YXXL motif in
DC-SIGN is not essential for Raf-1 activation, as shown by
the fact that DC-SIGN Y31A-expressing cells phosphory-
lated Raf-1 upon ManLAM stimulation (Figure 4D). In line
with this observation, we could not detect a role for Syk in
DC-SIGN signaling, because the Syk inhibitor piceatannol
did not prevent ManLAM-mediated IL-10 induction (Fig-
ure 2A). Moreover, we did not detect active Syk after
ManLAM binding to DC-SIGN on iDCs as determined by
flow cytometry and a kinase activity assay specific for Syk
(Figure S1 in the Supplemental Data available online). These
data demonstrate that the YXXL motif in DC-SIGN and Syk
activation is not essential to Raf-1 activation.
Raf-1 Activation by DC-SIGN Does Not Lead
to Extracellular Signal-Regulated Kinase Activation
Next, we set out to identify the downstream effectors of
Raf-1 that modulate TLR signaling. Several downstream608 Immunity 26, 605–616, May 2007 ª2007 Elsevier Inc.effectors of Raf-1 have been described, of which the
best characterized are the dual-specificity kinases MEK1
and MEK2, which lead to activation of ERK1 and ERK2
(Baccarini, 2005; Kolch, 2005; Wellbrock et al., 2004). Re-
cently, it has been described that the DC-SIGN-activating
antibody MR-1 induces ERK phosphorylation (Caparros
et al., 2006). We determined whether ERKs function as
downstream effectors of Raf-1 in the DC-SIGN-mediated
modulation of TLR signaling by performing a kinase assay
specific for ERK1 and ERK2. LPS strongly induced ERK
activation in iDCs after 10 min of stimulation, as previously
reported (Figure 3C; Arrighi et al., 2001; Kawai and Akira,
2006; Re and Strominger, 2001). Remarkably, we could
not detect any activation of ERK kinase activity after liga-
tion of DC-SIGN with ManLAM (Figure 3C). In accordance
with these results, we observed that MEK1/2 inhibitor
U0126 did not block ManLAM-induced enhancement of
the LPS-induced IL-10 mRNA expression (Figure 2A).
Our findings demonstrate that DC-SIGN signals through
a different Raf-1-dependent effector than the MEK-ERK
module.
DC-SIGN Signaling Results in Raf-1-Dependent
Phosphorylation of Serine Residue Ser276 of p65
Several studies have implied that Raf-1 plays a role in the
modulation of the transactivation activity of NF-kB, al-
though the mechanism remains unclear (Baumann et al.,
2000; Wellbrock et al., 2004). Signaling through all TLRs
leads to activation of NF-kB (Kawai and Akira, 2006), so
we investigated whether Raf-1-dependent DC-SIGN sig-
naling modulates TLR-induced NF-kB activity. We first
Immunity
DC-SIGN Induces p65 Acetylation via Raf-1Figure 4. DC-SIGN Signaling Activates Ras and Src and Pak Kinases to Induce Raf-1 Phosphorylation and Activation
(A) DC-SIGN binding to ManLAM induces active Ras. Active GTP-bound Ras was precipitated with Raf-RBD-GST from cell lysates of human iDCs
treatedwith LPS and/or ManLAM for 5min, resolved by SDS-PAGE, and detected by immunoblotting with anti-Ras. Total Raswas detected in lysates
to confirm equal amounts.
(B) ManLAM induces the phosphorylation of Ser338 and Tyr340 and Tyr341 on Raf-1 through Ras and the Src and Pak kinases. DCs were stimulated
as indicated for 10 min. Cells were pretreated with Tat-RasN17, the dominant-negative form of Ras, the Src kinase inhibitor PP2, or toxin B, an in-
hibitor of the Rho family GTPases, upstream effectors of Paks. Phosphorylated Raf-1 was measured by intracellular staining of DCs with anti-phos-
pho-c-Raf (Ser338) or anti-c-Raf (p Tyr340 or pTyr341), followed by incubation with PE-conjugated donkey anti-rabbit Ig and flow cytometry. A rep-
resentative experiment from at least two donors is shown.
(C) The Raf-1-mediated IL-10 upregulation byManLAM is dependent on Ras activation aswell as Src and Pak kinases. DCswere treatedwith different
inhibitors as described in (B), and IL-10 mRNA was determined as described in Figure 1A. Results are presented as the means ± SD from at least two
independent experiments.
(D) The YXXL motif of DC-SIGN is not essential to Raf-1 activation. Jurkat cells transduced with wild-type DC-SIGN and the Y31A mutant were in-
cubated with ManLAM, and phosphorylation of Raf-1 was determined as described in (B).examined the composition of the active NF-kB dimer,
because the components that make up the transcription
factor (p50, p52, p65, RelB, c-Rel) have different binding
affinities and transactivation features (Hayden and Ghosh,
2004; Saccani et al., 2003). LPS strongly induced the
nuclear translocation and DNA binding of p65 and p50,
whereas we could detect only a modest increase in bind-
ing of c-Rel and a negligible change in p52 and RelB bind-
ing in nuclear extracts from LPS-stimulated iDCs (Fig-
ure 5A). Stimulation of iDCs with ManLAM alone or in
combination with LPS did not induce the nuclear translo-
cation and binding of any of the NF-kB components
(Figure 5A). These data demonstrate that DC-SIGN sig-
naling does not induce translocation of NF-kB into the
nucleus.
NF-kB activity can be regulated by covalent modifica-
tions such as phosphorylation and acetylation (Hayden
and Ghosh, 2004). We determined the phosphorylation
status of the key serine residues Ser276 and Ser536.
Phosphorylation of Ser536 within the transactivation do-
mainwas detected upon stimulation of iDCswith LPS (Fig-
ure 5B). This observation is in accordance with previous
reports that phosphorylation of p65 on Ser536 is requiredfor LPS-dependent NF-kB activation (Yang et al., 2003).
Stimulation of iDCs with LPS and ManLAM together did
not further enhance phosphorylation of p65 (Figure 5B).
We could not detect any phosphorylation of Ser276 as
a result of either LPS or ManLAM stimulation (Figure 5C).
However, strikingly, combined triggering of TLR4 and
DC-SIGN signaling did result in phosphorylation of
Ser276 (Figure 5C), indicating that LPS-mediated activa-
tion of NF-kB is required in order to allow for ManLAM-
induced phosphorylation of p65 at Ser276. Phosphorylation
of Ser276 of p65 is a downstream target of Raf-1 in the
DC-SIGN signaling pathway, as shown by the abrogation
of the observed Ser276 phosphorylation after LPS +
ManLAM stimulation in the presence of the Raf inhibitor
(Figure 5C). Thus, only when TLR signaling has activated
NF-kB will DC-SIGN-mediated signaling result in phos-
phorylation of p65 at Ser276, supporting our data that
ManLAM binding to DC-SIGN induces IL-10 only after
TLR activation.
DC-SIGN Signaling Triggers Acetylation of p65
Phosphorylation of Ser276 of p65 has been linked to the
acetylation of p65 on several lysines, induced by bindingImmunity 26, 605–616, May 2007 ª2007 Elsevier Inc. 609
Immunity
DC-SIGN Induces p65 Acetylation via Raf-1Figure 5. DC-SIGN-Mediated Raf-1-Dependent Signaling Induces p65 Phosphorylation on Ser276 and Acetylation, after Concur-
rent TLR Signaling
(A) DC-SIGN signaling does not influence nuclear translocation of different NF-kB subunits. DNA-binding ELISA of the NF-kB subunits p65, RelB,
c-Rel, p50, and p52 in nuclear extracts of human iDCs treated as indicated for 1 hr. NF-kB was allowed to bind to oligonucleotides containing the
NF-kB-binding consensus sequence; specific antibodies were used to detect the different subunits within the bound complexes. Results are pre-
sented as the means ± SD from two independent experiments.
(B andC) DC-SIGN signaling induces p65 phosphorylation on Ser276 through Raf-1. ELISA of phospho-Ser536-p65 (B) or phospho-Ser276-p65 (C) in
cell lysates of human iDCs treated as indicated for 30 min; cells were preincubated for 2 hr with Raf inhibitor GW5074 as indicated. Results are pre-
sented as the means ± SD from three independent experiments.
(D) DC-SIGN induces acetylation of p65. ELISA with acetyl-lysine antibodies on captured p65 from cell lysates of human iDCs treated as indicated for
30 min; cells were preincubated with Raf inhibitor GW5074 as in (C). Results are presented as the means ± SD from three independent experiments.
(E) Acetylation of p65 is essential to ManLAM-induced IL-10 upregulation. Relative IL-10 mRNA production by human iDCs treated with different
ligands for 6 hr as indicated; cells were preincubated for 2 hr with anacardic acid (AA), an inhibitor of the histone acetyltransferases p300 and
CBP. IL-10 mRNA was determined as described in Figure 1A. Results are presented as the means ± SD from three independent experiments.of the histone acetyltransferases (HATs) CREB binding
protein (CBP) and p300 to the phosphorylated Ser276
residue (Zhong et al., 1998, 2002). Indeed, DC-SIGN and
TLR4 signaling cooperated in inducing acetylation of p65
(Figure 5D). We could not detect any p65 acetylation after
stimulation with either LPS or ManLAM alone (Figure 5D).
Similarly to phosphorylation of Ser276, acetylation of p65
could be blocked by the Raf inhibitor (Figure 5D). These
findings imply that the Raf-1-dependent signaling path-
way induced by DC-SIGN leads first to phosphorylation
of p65 on Ser276 and subsequently to its acetylation.
Acetylation of p65 has been described to regulate NF-
kB action on multiple levels (Chen and Greene, 2003).
We used anacardic acid, an inhibitor of CBP/p300-
specific HAT activity (Sun et al., 2006), to establish whether
the acetylation of p65 accounts for the modulation of the
TLR-induced IL-10 production by DC-SIGN. Strikingly,
the upregulation of TLR3-, TLR4-, and TLR5-induced
IL-10 mRNA expression after costimulation with ManLAM
was completely abrogated in the presence of anacardic
acid (Figure 5E), demonstrating that p65 acetylation plays610 Immunity 26, 605–616, May 2007 ª2007 Elsevier Inc.a central role in the upregulation of TLR-induced IL-10
production by DC-SIGN.
Not only IL10 but also other NF-kB-dependent cytokine
promoters are targeted; we observed a similar Raf-1-acet-
ylation-dependent induction of IL-8. Notably, ManLAM
binding to DC-SIGN also upregulated the early response
genes interferon b (IFNb) and IFN-stimulated gene 15
(ISG15), which are dependent on both NF-kB and IRF3
(Figure S2).
DC-SIGN-Induced Acetylation Prolongs
Transcriptional Activity of NF-kB and Enhances
Transcription Rate from the IL-10 Gene
Acetylation of p65 results in enhanced transcriptional
activity of NF-kB (Chen and Greene, 2003). First, we
examined the duration of NF-kB activation in DCs after
stimulation, by measuring DNA binding p65 in nuclear
extracts. After LPS stimulation, NF-kB remained active
for as long as 4 hr (Figure 6A). Strikingly, LPS + ManLAM
costimulation prolonged the nuclear activity of NF-kB to
Immunity
DC-SIGN Induces p65 Acetylation via Raf-1Figure 6. DC-SIGN-Induced Acetylation
Prolongs Nuclear p65 DNA Binding and
Enhances the IL-10 Transcription Rate
(A) DC-SIGN signaling prolongs nuclear p65
DNA binding compared to LPS signaling alone.
DNA binding was determined as described in
Figure 5A. Results are presented as the
means±SD from two independent experiments.
(B) Acetylation of p65 prolongs nuclear p65DNA
binding. ELISA of p65 in nuclear extracts of hu-
man iDCs treated similar as in (A); cells were pre-
incubated with Raf inhibitor GW5074 and HAT
inhibitor anacardic acid (AA) as in Figures 5C
and 5E. DNA binding was determined as in (A).
Results are presented as the means ± SD from
two independent experiments.
(C) DC-SIGN signaling enhances the IL10 tran-
scription rate. Relative IL-10 transcription rate
in nuclei isolated from human iDCs treated sim-
ilar as in (A); cells were preincubated for 2 hrwith
the blocking DC-SIGN antibody AZN-D2 as indi-
cated. Transcription by isolated nuclei was initi-
ated in the presence of 16-biotin-UTP; after 20
min of transcription, nuclei were lysed, RNA
with incorporated biotin was isolated, and quan-
titative real-time PCR analysis was performed to
determine the relative IL-10 RNA production.
The amount of RNA produced in 20min is repre-
sentative of the transcription rate. The IL-10RNA
production by LPS-stimulated cells was set at 1.
Results are presented as the means ± SD from
two independent experiments.at least 8 hr (Figure 6A) and was dependent on both Raf-1
activation and acetylation (Figure 6B).
The induction of IL-10 mRNA within 6 hr of LPS +
ManLAM stimulation (Figure 1B) suggests that the pro-
longed NF-kB activation from 4 to 8 hr is not the only
mechanism involved. Therefore, we determined the effect
of DC-SIGN signaling on the transcription rate from the
IL10 gene. Stimulation of iDCs with ManLAM enhanced
the LPS-induced IL10 transcription rate approximately
3-fold (Figure 6C). We could completely block this Man-
LAM-induced increase by the addition of the Raf and
HAT inhibitors (Figure 6C). Thus, the increase in IL-10 by
DCs after ManLAM and LPS stimulation is regulated at
the level of NF-kB by prolonging NF-kB activity and
enhancing the transcription rate from the IL10 gene,
both processes triggered by DC-SIGN through the Raf-1-
acetylation-dependent pathway.
Raf-1-Dependent Acetylation of p65 Is Central
to DC-SIGN-Mediated Cytokine Responses
to Pathogens
Next, we investigated whether intact mycobacteria also
induce the Raf-1-acetylation-dependent pathway in DCs
through triggering of DC-SIGN. Remarkably, M. tuber-
culosis, M. leprae, and M. bovis BCG all induced IL-
10 through DC-SIGN- and TLR-dependent signaling
pathways. The DC-SIGN-dependent signaling could be
inhibited by the Raf andHAT inhibitors (Figure 7).M. leprae
alone induced a low amount of IL-10 that could be furtherincreased by LPS (Figure 7). Besides mycobacteria, other
pathogens also target DC-SIGN on DCs to modulate im-
mune responses (van Kooyk and Geijtenbeek, 2003).
Here, we demonstrate that also fungi and viruses modu-
late cytokine responses through the DC-SIGN-mediated
Raf-1-acetylation-dependent pathway (Figure 7). Similarly
to the mycobacteria, Candida albicans alone induced
IL-10 production through coactivation of DC-SIGN and
TLR signaling pathways. S. cerevisiae mannan induced
IL-10 only in the presence of LPS (Figure 7). Human im-
munodeficiency virus-1 (HIV-1) also required prior TLR
activation to modulate cytokine responses through
DC-SIGN, whereas measles virus alone induced IL-10,
because measles virus triggers both DC-SIGN (de Witte
et al., 2006) and TLR2 (Bieback et al., 2002) signaling
(Figure 7). The pathogens induced the Raf-1-acetyla-
tion-dependent pathway to enhance IL-10 production,
because the cytokine response was decreased substan-
tially through the Raf and HAT inhibitors. These data
demonstrate that the DC-SIGN-mediated Raf-1-acetyla-
tion-dependent signaling pathway plays an important
role in the regulation of DC-specific cytokine responses
to pathogens.
DISCUSSION
TLRs control multiple dendritic cell functions and activate
signals that are critically involved in adaptive immune
responses. Little is known about how individual TLRImmunity 26, 605–616, May 2007 ª2007 Elsevier Inc. 611
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nity to a given pathogen and how other PRRs contribute
to the TLR-induced signaling pathways. Here we describe
a molecular mechanism by which mycobacteria, fungi,
and viruses target DC-SIGN to modulate TLR signaling
in human DCs. We demonstrate that ManLAM binding to
DC-SIGN on human DCs activates the serine and threo-
nine kinase Raf-1, which leads to phosphorylation and
subsequent acetylation of p65, the activating subunit of
the transcription factor NF-kB (for model, see Figure S3).
Acetylation of p65 has a dual effect on transcription activ-
ity that strongly enhances IL-10 expression by DCs: p65
acetylation prolongs NF-kB activity and increases the
transcription rate from the IL10 gene. Notably, although
Raf-1 is activated by DC-SIGN triggering alone, the acet-
ylation of p65 through Raf-1 occurs only when NF-kB is
activated by TLRs. Thus, the DC-SIGN-dependent signal-
ing pathway is controlled and can influence DC function
only after the DC has sensed pathogens through TLR
activation.
Figure 7. Mycobacteria, Fungi, and Viruses Target DC-SIGN
to Modulate TLR Signaling through a Raf-1- and Acetylation-
Dependent Signaling Pathway
iDCs were stimulated as described in Figure 5E with pathogens in
combination with LPS as indicated. Raf and HAT inhibitors were
used to determine whether these pathogens signal through DC-
SIGN-mediated Raf-1-acetylation-dependent pathway. IL-10 mRNA
was determined as described in Figure 1A. A representative experi-
ment from two donors is shown.612 Immunity 26, 605–616, May 2007 ª2007 Elsevier Inc.We have identified a role for Raf-1 in controlling adap-
tive immune responses through activation by DC-SIGN.
The role of Raf-1 in proliferation, differentiation, survival,
and motility has been studied intensely, often focusing
on its role as an effector of Ras in the signaling cascade
leading to ERK activation through the activation of anti-
gen, cytokine, or growth factor receptors (Baccarini,
2005; Kolch, 2005; Wellbrock et al., 2004). DC-SIGN trig-
gering results in Ras activation and subsequent activation
of Raf-1 through phosphorylation by Src and Pak family
kinases. It remains to be determined how ligand binding
to DC-SIGN couples to Ras activation. Studies on Dec-
tin-1 and CLEC-2 signaling suggested a possible role for
the cytoplasmic YXXL motif through Syk kinase activation
(Brown, 2006; Rogers et al., 2005; Suzuki-Inoue et al.,
2006). However, our results exclude a role for the YXXL
motif and Syk in DC-SIGN-dependent Raf-1 activation.
ERK has been implicated as a downstream effector of
Raf-1, but our data demonstrate that Raf-1 activation
through DC-SIGN affects cytokine responses indepen-
dently of ERK. This is in line with a previous finding that
ERK is not required for Raf-1-dependent activation of
NF-kB (Baumann et al., 2000). However, our results con-
tradict data showing that ERK phosphorylation can be
induced with a DC-SIGN-activating antibody (Caparros
et al., 2006); an explanation might be that the antibody-
induced signaling differs from that of pathogens.
A link between NF-kB as the downstream effector of
Raf-1 has repeatedly surfaced in studies over the past
dozen years (Baumann et al., 2000; Wellbrock et al.,
2004), but the underlying mechanism has remained
elusive so far. Here, we have identified the molecular
mechanism by which Raf-1 affects NF-kB activity: Raf-1
activation through DC-SIGN results in acetylation of the
NF-kB subunit p65. DC-SIGN-mediated acetylation of
NF-kB leads to both increased and prolonged transcrip-
tional activation from the IL10 promoter. This dual effect
of DC-SIGN signaling can be attributed to acetylation of
different lysine residues of p65. Acetylation of Lys310 is
required for full transcriptional activity of p65, possibly
creating a binding site for an as yet unidentified transcrip-
tional coactivator increasing the transcription rate (Chen
and Greene, 2003; Chen et al., 2005). Acetylation of
Lys218 and Lys221 of p65 impairs the assembly with
IkB, preventing the inactivation and nuclear export of
NF-kB to the cytoplasm, explaining the observed pro-
longed NF-kB response. It is tempting to speculate that
the recruitment of the HATs CBP and p300 by p65 to the
IL10 promoter might also facilitate transcription by chang-
ing the local status of histone acetylation. Recently, it has
been shown that LPS stimulation is accompanied by chro-
matin remodeling of secondary response genes, such
as IL10, but the histone acetylation levels remain low
(Ramirez-Carrozzi et al., 2006). An increase in acetylation
could positively influence transcription (Li et al., 2007).
Thus, acetylation is crucial to the DC-SIGN-enhanced
transcriptional activity in DCs.
In contrast to the activation of Raf-1 by DC-SIGN, the
acetylation of p65 induced by DC-SIGN occurs only after
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duce NF-kB activation, but enhances its transcriptional
activity only after other signaling routes have induced
the release of NF-kB from its inhibitor IkB, indicating that
the DC-SIGN signaling route functions as a modulatory
pathway (Figure S3). Acetylation of p65 is known to be de-
pendent on phosphorylation of a specific serine residue,
Ser276 (Chen et al., 2005; Zhong et al., 1998). Indeed,
our data demonstrate that activation of Raf-1 via triggering
of DC-SIGN leads to the phosphorylation of serine residue
Ser276 of p65. However, phosphorylation at this residue
occurs only when NF-kB is released from its inhibitor IkB
by TLR activation and translocates to the nucleus (Kawai
and Akira, 2006). TLR triggering also leads to phosphory-
lation of Ser536, which is both necessary and sufficient
for the LPS-mediated transactivation of NF-kB (Schmitz
et al., 2004; Yang et al., 2003). Acetylation of p65 after
DC-SIGN triggering is presumably a direct result of the
DC-SIGN-induced phosphorylation of Ser276, because
recruitment of the HATs p300 and CBP to p65 depends
on prior phosphorylation of Ser276 (Chen et al., 2005;
Zhong et al., 1998, 2002). Unstimulated DCs already
show high p300/CBP acetyltransferase activities (data
not shown), suggesting that the acetyltransferases are
poised to respond immediately upon TLR-dependent
nuclear translocation of NF-kB and DC-SIGN-Raf-1-
dependent phosphorylation of p65.
The identity of the kinase responsible for the phosphor-
ylation of Ser276 of p65 as a result of DC-SIGN-induced
Raf-1 activation is still under investigation. Our results
point toward a nuclear kinase, because nuclear trans-
location of active NF-kB that is due to TLR signaling is re-
quired before Raf-1-mediated phosphorylation of Ser276
is detected. Protein kinase A (PKA) and mitogen- and
stress-activated kinase-1 (MSK1) have previously been
reported to phosphorylate Ser276 of p65 (Vermeulen
et al., 2003; Zhong et al., 1998); however, an inhibitor of
these kinases, H89, did not inhibit the ManLAM-induced
IL-10 upregulation.
DC-SIGN signaling modulates not only TLR4- but also
TLR3- and TLR5-induced cytokine responses. The endo-
some-resident TLR3 signals through TRIF, while TLR5 on
the outer membrane depends on the binding of MyD88,
whereas TLR4 induces bothMyD88- and TRIF-dependent
pathways, all culminating in the activation of the transcrip-
tion factor NF-kB (Kawai and Akira, 2006).M. tuberculosis,
M. leprae, M. bovis BCG, and Candida albicans trigger
TLR2- and/or TLR4-mediated signaling through their
cell-wall components (Abel et al., 2002; Krutzik et al.,
2003; Netea et al., 2006). Our data demonstrate that these
pathogens simultaneously activate the different pathogen
receptors DC-SIGN and TLR on DCs, thereby inducing
pathogen-specific anti-inflammatory cytokine responses.
The weak induction of IL-10 by M. leprae is probably due
to the activation of only TLR2 (Krutzik et al., 2003), be-
cause simultaneous TLR4 triggering by LPS strongly
increased the IL-10 response through the Raf-1-acetyla-
tion-dependent pathway. This suggests that the cytokine
response is dependent on which TLR is triggered. Nota-bly, TLR activation of monocytes induces the expression
of DC-SIGN (Krutzik et al., 2005), providing a further ex-
ample of how the TLR and DC-SIGN pathways reinforce
each other. HIV-1 induces IL-10 upregulation through
DC-SIGN only after TLR4 triggering by LPS, whereas
measles virus induces IL-10 in the absence of LPS, be-
cause it binds to both TLR2 (Bieback et al., 2002) and
DC-SIGN (de Witte et al., 2006). Inhibition of Raf-1 activa-
tion or p65 acetylation resulted with all the DC-SIGN-path-
ogen interactions in a decrease of IL-10, suggesting that
this Raf-1-dependent acetylation pathway might be a po-
tential target for therapies to prevent immunosuppression
during infections. Elevated amounts of IL-10 that can
cause some of the immunosuppressive effects of HIV-1
have been found consistently in AIDS patients (Redpath
et al., 2001). Notably, a recent study demonstrated that
AIDS patients also have elevated amounts of microbial
LPS in their serum (Brenchley et al., 2006). Our data
strongly suggest that the concerted effect of LPS and
HIV-1 in these patients will modulate DC functions through
the Raf-1-acetylation-dependent pathway resulting in
the elevated IL-10 amounts observed in AIDS patients
(Redpath et al., 2001).
We have shown that DC-SIGN signaling converges with
TLR signaling at the level of NF-kB to modulate pathogen-
specific cytokine responses by DCs. Our data have iden-
tified an important role for Raf-1 in the differentiation of
immune responses against pathogens, and the Raf-1-
dependent acetylation of p65 might be a general mecha-
nism by which DC-SIGN, and maybe other PRRs, modu-
late the various NF-kB-dependent immune responses.
The modulatory effect of DC-SIGN on NF-kB coupled
with its well-reported binding to a wide array of pathogens
(van Kooyk and Geijtenbeek, 2003) further confirms the
important role of DC-SIGN in the regulation of DC-specific
immune responses to pathogens. These data suggest that
this signaling pathwaymight be a promising target in com-
bating immune suppression induced by pathogens.
EXPERIMENTAL PROCEDURES
Cells, Stimulation, and Inhibition
Immature DCs were cultured as described before (Geijtenbeek et al.,
2003). In brief, human bloodmonocytes were isolated from buffy coats
(Sanquin bloodbank Amsterdam, the Netherlands) by use of a Ficoll
gradient and a subsequent CD14 selection step with a MACS system
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). Purified
monocytes were differentiated into immature DCs in the presence of
500 U/ml interleukin-4 and 800 U/ml granulocyte-macrophage
colony-stimulating factor (Schering-Plough, Brussels, Belgium). DCs
were used for experiments at day 6 and 7. This study was performed
in accordance with the ethical guidelines of the VU University Medical
Center.
Jurkat cells expressing DC-SIGN mutants were generated by retro-
viral transduction with lentiviral vectors as described (Arrighi et al.,
2004).
Cellswere stimulatedwith different TLR ligands and pathogens in the
presence or absence of signaling inhibitors as described in the Supple-
mental Experimental Procedures. The Ras inhibitor Tat-RasN17 (a gift
fromD.Hall, University ofWisconsin,Madison,WI) and the control pep-
tide Tat-HA (a gift from S. Dowdy, UCSD School of Medicine, La Jolla,
CA) were expressed and purified as described previously (RemansImmunity 26, 605–616, May 2007 ª2007 Elsevier Inc. 613
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bated with Tat proteins for 1 hr prior to stimulation.
IL-10 Production
For the detection of IL-10 protein, culture supernatants were harvested
after 24 hr of stimulation and analyzed for IL-10 by ELISA (Biosource
International, Camarillo, CA).
Quantitative Real-Time PCR and mRNA Half-Life Determination
mRNA was specifically isolated with the mRNA capture kit (Roche,
Basel, Switzerland), and cDNA was synthesized with the Reverse tran-
scriptase kit (Promega, Madison, WI). For the determination of mRNA
half-life, DCs were stimulated for 3 hr prior to the addition of 10 mg/ml
actinomycin D (Sigma) to block transcription; mRNA was then isolated
at 20 min time periods.
For real-time PCR analysis, PCR amplification was performed with
the SYBR green method as described (Garcia-Vallejo et al., 2004).
Details are described in Supplemental Experimental Procedures.
RNA Interference
DCs were transfected with 100 nM siRNA with transfection reagens
DF4 (Dharmacon, Lafayette, CO), according to the manufacturer’s
protocol. The siRNAs used were: Raf-1 SMARTpool (M-003601-00);
nontargeting siRNA pool (D-001206-13), as a control (Dharmacon).
This protocol resulted in nearly 100% transfection efficiency as
determined by flow cytometry of cells transfected with siGLO-RISC
free-siRNA (D-001600-01). At 72 hr after transfection, cells were
used for experiments. Silenced expression of Raf-1 was confirmed
at the mRNA level by quantitative real-time PCR.
Ras Pull-Down Assay
Active GTP-bound Ras was precipitated from cell lysates with
Raf-RBD-GST (Upstate Biotechnology, Lake Placid, NY) as previously
described (Remans et al., 2004), resolved by SDS-PAGE, and
detected by immunoblotting with anti-Ras mAbs (BD Transduction
Laboratories, Lexington, KY). Total Raswas detected in lysates to con-
firm equal amounts.
Kinase Activity Assays for Raf-1, B-Raf, Syk, and ERK
B-Raf or Raf-1 was isolated from cell lysates by specific antibodies
(Upstate). The immuno-complexes were incubated with 0.5 mg inactive
MEK1 (Santa Cruz Biotechnology, Santa Cruz, CA) as a substrate at
30C. After 20 min, 0.4 mg inactive ERK2 (Upstate) and 0.4 mg biotin-
MBP (Chemicon, Temecula, CA) were added as substrate for activated
MEK1, and after 30 min at 30C, biotin-MBP was captured in strepta-
vidin-coated wells and phosphorylation was determined with mouse
anti-phospho-MBP (Chemicon), which is a measure for Raf-1 activity.
Further details are described in the Supplemental Experimental
Procedures.
Phosphorylation of Raf-1 and Syk
Phosphorylation of Raf-1 was measured by flow cytometry with rabbit
anti-phospho-c-Raf (Ser338) mAb (Cell Signaling, Danvers, MA) and
rabbit anti-c-Raf (pTyr340, Tyr341) pAb (Calbiochem). Syk phosphor-
ylation was detected by rabbit anti-phospho Syk (Tyr525/526) mAb
(Cell Signaling). Details are described in the Supplemental Experimen-
tal Procedures.
DNA Binding, Acetylation, and Phosphorylation of NF-kB
DC nuclear extracts were prepared with the NucBuster protein extrac-
tion kit (Novagen, Madison, WI), and 5 mg of nuclear extract was used
to determine the specific subunits within the DNA binding NF-kB
dimers with the TransAM NF-kB family kit (Active Motif, Carlsbad,
CA), according to the manufacturer’s protocol.
p65 from cell lysates was captured with the Pathscan phospho-
NF-kB p65 (Ser536) sandwich ELISA kit (Cell Signaling), according to
the manufacturer’s protocol. Total p65 was detected with rabbit anti-
p65 pAbs (Active Motif), p65 phosphorylated at Ser276 or Ser536614 Immunity 26, 605–616, May 2007 ª2007 Elsevier Inc.was detected with rabbit anti-phospho-p65(Ser276) or -p65(Ser536)
pAbs (Cell Signaling), and acetylated p65 was detected with rabbit
anti-acetyl-lysine pAbs (Upstate).
Nuclear Run-on
Nuclei were isolated from DCs. Transcription was initiated by the addi-
tion of transcription buffer containing 16-biotin-UTP (Roche) and
allowed to proceed at 26C for 20 min. Nuclei were lysed, and newly
synthesized biotin-containing RNA was captured in streptavidin-
coated tubes with the mRNA capture kit (Roche). cDNA synthesis
and real-time PCR analysis was performed as described above.
Details are described in Supplemental Experimental Procedures.
Statistical Analysis
Data are presented as the means ± standard deviations derived from
at least three independent experiments unless otherwise stated. Sta-
tistical analyses were performed on the data via the Student’s t test
for paired observations. Statistical significance of the data was set at
p < 0.05.
Supplemental Data
Three figures and Experimental Procedures are available at http://
www.immunity.com/cgi/content/full/26/5/605/DC1/.
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